Maintenance fees coming due

Epicentrx, Inc.

7 maintenance fees come due in the 12 months from Nov 14, 2026, the next on Nov 30, 2026. Unpaid by Jun 1, 2027, that one lapses early.

A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.

Patent	Title	Holder	Status	Fee due	Lapses if unpaid	Expires	Confidence
US 11,660,286	Methods and Compositions Comprising a Nitrite-Reductase Promoter for Treatment of Medical Disorders and Preservation of Blood Products Epicentrx, Inc. In force Fee due Nov 30, 2026 Lapses if unpaid Jun 1, 2027 Term ends Oct 5, 2032 · High confidence	Epicentrx, Inc.	In force	Nov 30, 2026	Jun 1, 2027	Term ends Oct 5, 2032	High confidence
US 10,342,778	Treatment of Brain Metastases Using Organonitro Compound Combination Therapy Epicentrx, Inc. In force Fee due Jan 9, 2027 Lapses if unpaid Jul 9, 2027 Term ends Apr 1, 2037 · High confidence	Epicentrx, Inc.	In force	Jan 9, 2027	Jul 9, 2027	Term ends Apr 1, 2037	High confidence
US 11,701,351	Treatment of Gliomas Using Organonitro Compound Combination Therapy Epicentrx, Inc. In force Fee due Jan 18, 2027 Lapses if unpaid Jul 19, 2027 Term ends Oct 28, 2036 · High confidence	Epicentrx, Inc.	In force	Jan 18, 2027	Jul 19, 2027	Term ends Oct 28, 2036	High confidence
US 11,744,859	Compositions and Methods for Parenteral Administration of Therapeutic Agents Epicentrx, Inc. In force Fee due Mar 5, 2027 Lapses if unpaid Sep 7, 2027 Term ends Dec 23, 2038 · High confidence	Epicentrx, Inc.	In force	Mar 5, 2027	Sep 7, 2027	Term ends Dec 23, 2038	High confidence
US 9,139,519	Organonitro Thioether Compounds and Medical Uses Thereof Epicentrx, Inc. In force Fee due Mar 22, 2027 Lapses if unpaid Sep 22, 2027 Term ends May 18, 2032 · High confidence	Epicentrx, Inc.	In force	Mar 22, 2027	Sep 22, 2027	Term ends May 18, 2032	High confidence
US 11,834,492	Human IL-10 Receptor Alpha Fusion Proteins Epicentrx, Inc. In force Fee due Jun 5, 2027 Lapses if unpaid Dec 6, 2027 Term ends Dec 22, 2038 · High confidence	Epicentrx, Inc.	In force	Jun 5, 2027	Dec 6, 2027	Term ends Dec 22, 2038	High confidence
US 10,543,208	Treatment of Gliomas Using Organonitro Compound Combination Therapy Epicentrx, Inc. In force Fee due Jul 28, 2027 Lapses if unpaid Jan 28, 2028 Term ends Oct 28, 2036 · High confidence	Epicentrx, Inc.	In force	Jul 28, 2027	Jan 28, 2028	Term ends Oct 28, 2036	High confidence

7 of 7 patents shown. Soonest fee due date first, then patent number.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.